BlackRock, Inc. - 31 Mar 2025 SCHEDULE 13G/A Report for TScan Therapeutics, Inc. Common Stock (TCRX)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: TScan Therapeutics, Inc. Common Stock
Symbol: TCRX
Shares outstanding: 52,330,056 shares
Disclosed Ownership: 2,825,823 shares
Ownership: 5.4%
Form type: SCHEDULE 13G/A
Filing time: 24 Apr 2025, 09:12:39 UTC
Date of event: 31 Mar 2025
Next filing: 16 Jul 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	5.4%	2,825,823	2,802,967	0	Spencer Fleming	Managing Director